NAC amino acid offers a potential therapeutic alternative in psychiatric disorders

(European College of Neuropsychopharmacology) According to research presented at the 26th ECNP Congress, clinical trials in an amino acid, N-Acetyl Cysteine shows effects on anti-oxidant and anti-inflammatory pathways in both patients with schizophrenia and depression.